Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies
Authors
Keywords
-
Journal
Nutrients
Volume 13, Issue 2, Pages 537
Publisher
MDPI AG
Online
2021-02-14
DOI
10.3390/nu13020537
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Scopolamine, a toxin-induced experimental model used for research in Alzheimer’s disease
- (2020) Win Ning Chen et al. CNS & Neurological Disorders-Drug Targets
- Caffeine induces neurobehavioral effects through modulating neurotransmitters
- (2020) Fawaz Alasmari SAUDI PHARMACEUTICAL JOURNAL
- Chlorogenic Acid Alleviates Aβ25-35-Induced Autophagy and Cognitive Impairment via the mTOR/TFEB Signaling Pathway
- (2020) Lijuan Gao et al. Drug Design Development and Therapy
- Association of Coffee, Decaffeinated Coffee and Caffeine Intake from Coffee with Cognitive Performance in Older Adults: National Health and Nutrition Examination Survey (NHANES) 2011–2014.
- (2020) Xue Dong et al. Nutrients
- Caffeine Consumption in Children: Innocuous or Deleterious? A Systematic Review
- (2020) Yeyetzi C. Torres-Ugalde et al. International Journal of Environmental Research and Public Health
- Coffee, Caffeine, and Health
- (2020) Rob M. van Dam et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis
- (2020) Yun Chen et al. NEURON
- An outlook on the role of decaffeinated coffee in neurodegenerative diseases
- (2019) Raffaella Colombo et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Ingredients in Zijuan Pu’er Tea Extract Alleviate β-Amyloid Peptide Toxicity in a Caenorhabditis elegans Model of Alzheimer’s Disease Likely through DAF-16
- (2019) Fangzhou Du et al. MOLECULES
- The impact of curcumin and its modified formulations on Alzheimer's disease
- (2019) Tahereh Farkhondeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Natural Compounds for Alzheimer’s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies
- (2019) Stephanie Andrade et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Natural Products in Alzheimer’s Disease Therapy: Would Old Therapeutic Approaches Fix the Broken Promise of Modern Medicines?
- (2019) Habtemariam MOLECULES
- Current and Future Treatments in Alzheimer's Disease
- (2019) Alireza Atri SEMINARS IN NEUROLOGY
- Green Tea Intake and Risks for Dementia, Alzheimer’s Disease, Mild Cognitive Impairment, and Cognitive Impairment: A Systematic Review
- (2019) Saki Kakutani et al. Nutrients
- Benefits of curcumin in brain disorders
- (2019) Abid Bhat et al. BIOFACTORS
- Advance of sporadic Alzheimer's disease animal models
- (2019) Lili Zhang et al. MEDICINAL RESEARCH REVIEWS
- Diet and Alzheimer's dementia – Nutritional approach to modulate inflammation
- (2019) Katarzyna Szczechowiak et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Association between caffeine intake and cognitive function in adults; effect modification by sex: Data from National Health and Nutrition Examination Survey (NHANES) 2013–2014
- (2019) Sohrab Iranpour et al. CLINICAL NUTRITION
- The cellular and molecular processes associated with scopolamine-induced memory deficit: A model of Alzheimer's biomarkers
- (2019) Kim San Tang LIFE SCIENCES
- Caffeine Consumption During Pregnancy Accelerates the Development of Cognitive Deficits in Offspring in a Model of Tauopathy
- (2019) Stefania Zappettini et al. Frontiers in Cellular Neuroscience
- Role of phytochemicals as nutraceuticals for cognitive functions affected in ageing
- (2019) Melanie‐Jayne R. Howes et al. BRITISH JOURNAL OF PHARMACOLOGY
- Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
- (2019) Justin M. Long et al. CELL
- Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
- (2019) Sebastian Palmqvist et al. EMBO Molecular Medicine
- Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's disease
- (2019) Michela Rosini et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Ilex paraguariensis extract provides increased resistance against oxidative stress and protection against Amyloid beta-induced toxicity compared to caffeine in Caenorhabditis elegans
- (2019) Marina Lopes Machado et al. NUTRITIONAL NEUROSCIENCE
- Effect of Caffeine and Other Methylxanthines on Aβ-Homeostasis in SH-SY5Y Cells
- (2019) Janitschke et al. Biomolecules
- Caffeine May Abrogate LPS-Induced Oxidative Stress and Neuroinflammation by Regulating Nrf2/TLR4 in Adult Mouse Brains
- (2019) Badshah et al. Biomolecules
- Linking APOE-ε4, blood-brain barrier dysfunction, and inflammation to Alzheimer's pathology
- (2019) Joost M. Riphagen et al. NEUROBIOLOGY OF AGING
- The neurochemistry of agitation in Alzheimer’s disease: a systematic review
- (2018) Kathy Y. Liu et al. AGEING RESEARCH REVIEWS
- The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
- (2018) Harald Hampel et al. BRAIN
- Caffeine: A Potential Protective Agent Against Cognitive Decline in Alzheimer’s Disease
- (2018) Azhar Hussain et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Molecular biomarkers of Alzheimer's disease: progress and prospects
- (2018) Tammaryn Lashley et al. Disease Models & Mechanisms
- The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at ‘Type 3 Diabetes’, Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments
- (2018) Suzanne M. de la Monte et al. JOURNAL OF ALZHEIMERS DISEASE
- Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer’s Disease
- (2018) Christopher R. Beam et al. JOURNAL OF ALZHEIMERS DISEASE
- Sex differences in Alzheimer disease — the gateway to precision medicine
- (2018) Maria Teresa Ferretti et al. Nature Reviews Neurology
- Use of curcumin in diagnosis, prevention, and treatment of Alzheimer's disease
- (2018) Kun Zhang et al. Neural Regeneration Research
- Deficits in synaptic function occur at medial perforant path-dentate granule cell synapses prior to Schaffer collateral-CA1 pyramidal cell synapses in the novel TgF344-Alzheimer's Disease Rat Model
- (2018) Lindsey A. Smith et al. NEUROBIOLOGY OF DISEASE
- Blockade of adenosine A 2A receptors recovers early deficits of memory and plasticity in the triple transgenic mouse model of Alzheimer's disease
- (2018) António C. Silva et al. NEUROBIOLOGY OF DISEASE
- Evaluation of antioxidant and anti-inflammatory efficacy of caffeine in rat model of neurotoxicity
- (2018) Eman N. Hosny et al. NUTRITIONAL NEUROSCIENCE
- Guarana (Paullinia cupana) Extract Protects Caenorhabditis elegans Models for Alzheimer Disease and Huntington Disease through Activation of Antioxidant and Protein Degradation Pathways
- (2018) Patrícia Ferreira Boasquívis et al. Oxidative Medicine and Cellular Longevity
- Association of Tea Consumption with Risk of Alzheimer’s Disease and Anti-Beta-Amyloid Effects of Tea
- (2018) Curt Polito et al. Nutrients
- Habitual coffee consumption and cognitive function: a Mendelian randomization meta-analysis in up to 415,530 participants
- (2018) Ang Zhou et al. Scientific Reports
- Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease
- (2018) Emilie Faivre et al. Frontiers in Molecular Neuroscience
- Application of Ferulic Acid for Alzheimer’s Disease: Combination of Text Mining and Experimental Validation
- (2018) Guilin Meng et al. Frontiers in Neuroinformatics
- Long-term Treatment with Low-Dose Caffeine Worsens BPSD-Like Profile in 3xTg-AD Mice Model of Alzheimer’s Disease and Affects Mice with Normal Aging
- (2018) Raquel Baeta-Corral et al. Frontiers in Pharmacology
- Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
- (2018) C. Cheignon et al. Redox Biology
- Alzheimer’s disease hypothesis and related therapies
- (2018) Xiaoguang Du et al. Translational Neurodegeneration
- Alzheimer Disease
- (2018) John E. Morley et al. CLINICS IN GERIATRIC MEDICINE
- Caffeine Synergizes with Another Coffee Component to Increase Plasma GCSF: Linkage to Cognitive Benefits in Alzheimer's Mice
- (2018) Chuanhai Cao et al. JOURNAL OF ALZHEIMERS DISEASE
- Progressive Age-Related Cognitive Decline in Tau Mice
- (2018) Ann Van der Jeugd et al. JOURNAL OF ALZHEIMERS DISEASE
- Caffeine Consumption Prevents Memory Impairment, Neuronal Damage, and Adenosine A2A Receptors Upregulation in the Hippocampus of a Rat Model of Sporadic Dementia
- (2018) Janaína Espinosa et al. JOURNAL OF ALZHEIMERS DISEASE
- Nutrition and prevention of cognitive impairment
- (2018) Nikolaos Scarmeas et al. LANCET NEUROLOGY
- Roasted Coffee Reduces β-Amyloid Production by Increasing Proteasomal β-Secretase Degradation in Human Neuroblastoma SH-SY5Y Cells
- (2018) Kazuya Fukuyama et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Mendelian Randomization Studies of Coffee and Caffeine Consumption
- (2018) Marilyn Cornelis et al. Nutrients
- The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease
- (2018) Lucrezia Cellai et al. Frontiers in Neuroscience
- Computational and in-vitro validation of natural molecules as potential Acetylcholinesterase inhibitors and neuroprotective agents
- (2018) Ashwani Kumar et al. Current Alzheimer Research
- Role of purinergic receptors in the Alzheimer’s disease
- (2018) Marek Cieślak et al. Purinergic Signalling
- Caffeine in the Diet: Country-Level Consumption and Guidelines
- (2018) Celine Reyes et al. Nutrients
- Coffee Consumption and Risk of Dementia and Alzheimer’s Disease: A Dose-Response Meta-Analysis of Prospective Studies
- (2018) Susanna Larsson et al. Nutrients
- More than just caffeine: psychopharmacology of methylxanthine interactions with plant-derived phytochemicals
- (2018) Julius Schuster et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents
- (2017) Marie Jouanne et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The present and future of pharmacotherapy of Alzheimer’s disease: A comprehensive review
- (2017) Abhinav Anand et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children
- (2017) Daniele Wikoff et al. FOOD AND CHEMICAL TOXICOLOGY
- Role of Glutamate and NMDA Receptors in Alzheimer’s Disease
- (2017) Rui Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Mouse Models of Alzheimer’s Disease
- (2017) Gisela Esquerda-Canals et al. JOURNAL OF ALZHEIMERS DISEASE
- Combination therapy with octyl gallate and ferulic acid improves cognition and neurodegeneration in a transgenic mouse model of Alzheimer's disease
- (2017) Takashi Mori et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Why do so many clinical trials of therapies for Alzheimer's disease fail?
- (2017) Roy M Anderson et al. LANCET
- Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases
- (2017) Maria H. Madeira et al. MEDIATORS OF INFLAMMATION
- Does caffeine influence the anticholinesterase and antioxidant properties of donepezil? Evidence from in vitro and in vivo studies
- (2017) Ganiyu Oboh et al. METABOLIC BRAIN DISEASE
- Effects of Long-Term Caffeine Consumption on the Adenosine A1 Receptor in the Rat Brain: an In Vivo PET Study with [18F]CPFPX
- (2017) Danje Nabbi-Schroeter et al. MOLECULAR IMAGING AND BIOLOGY
- Health benefits of methylxanthines in neurodegenerative diseases
- (2017) Ainhoa Oñatibia-Astibia et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Chronic nicotine attenuates behavioral and synaptic plasticity impairments in a streptozotocin model of Alzheimer’s disease
- (2017) I.M. Esteves et al. NEUROSCIENCE
- Potential benefits of phytochemicals against Alzheimer's disease
- (2017) Emma L. Wightman PROCEEDINGS OF THE NUTRITION SOCIETY
- Modifiable pathways in Alzheimer’s disease: Mendelian randomisation analysis
- (2017) Susanna C Larsson et al. BMJ-British Medical Journal
- Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes
- (2017) Robin Poole et al. BMJ-British Medical Journal
- Modifiable pathways in Alzheimer’s disease: Mendelian randomisation analysis
- (2017) Susanna C Larsson et al. BMJ-British Medical Journal
- Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes
- (2017) Robin Poole et al. BMJ-British Medical Journal
- The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer’s disease: an overview of pre-clinical studies and translational perspectives in clinical practice
- (2017) Marco Cascella et al. Infectious Agents and Cancer
- Meta Analysis of Human AlzGene Database: Benefits and Limitations of Using C. elegans for the Study of Alzheimer's Disease and Co-morbid Conditions
- (2017) Behrad Vahdati Nia et al. Frontiers in Genetics
- The Safety of Ingested Caffeine: A Comprehensive Review
- (2017) Jennifer L. Temple et al. Frontiers in Psychiatry
- Caffeine Suppresses Amyloid-β Levels in Plasma and Brain of Alzheimer's Disease Transgenic Mice
- (2017) Chuanhai Cao et al. JOURNAL OF ALZHEIMERS DISEASE
- Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study
- (2017) Marjo H. Eskelinen et al. JOURNAL OF ALZHEIMERS DISEASE
- Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-β Levels in Aged Alzheimer's Disease Mice
- (2017) Gary W. Arendash et al. JOURNAL OF ALZHEIMERS DISEASE
- Chronic Caffeine Consumption Prevents Memory Disturbance in Different Animal Models of Memory Decline
- (2017) Rodrigo A. Cunha et al. JOURNAL OF ALZHEIMERS DISEASE
- Caffeine Protects Against Disruptions of the Blood-Brain Barrier in Animal Models of Alzheimer's and Parkinson's Diseases
- (2017) Xuesong Chen et al. JOURNAL OF ALZHEIMERS DISEASE
- Caffeine and Adenosine
- (2017) Joaquim A. Ribeiro et al. JOURNAL OF ALZHEIMERS DISEASE
- Alzheimer’s disease: experimental models and reality
- (2016) Eleanor Drummond et al. ACTA NEUROPATHOLOGICA
- Brain atrophy in Alzheimer’s Disease and aging
- (2016) Lorenzo Pini et al. AGEING RESEARCH REVIEWS
- Neuroinflammation in Alzheimer's disease: Current evidence and future directions
- (2016) Valeria Calsolaro et al. Alzheimers & Dementia
- Swertisin, a C-glucosylflavone, ameliorates scopolamine-induced memory impairment in mice with its adenosine A1 receptor antagonistic property
- (2016) Hyung Eun Lee et al. BEHAVIOURAL BRAIN RESEARCH
- In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer’s Disease Treatment
- (2016) Babar Ali et al. CNS & Neurological Disorders-Drug Targets
- Alzheimer's disease: Targeting the Cholinergic System
- (2016) Talita H. Ferreira-Vieira et al. Current Neuropharmacology
- Effects of caffeic acid on learning deficits in a model of Alzheimer's disease
- (2016) Yunliang Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- How does adenosine control neuronal dysfunction and neurodegeneration?
- (2016) Rodrigo A. Cunha JOURNAL OF NEUROCHEMISTRY
- Action of Caffeine as an Amyloid Inhibitor in the Aggregation of Aβ16–22 Peptides
- (2016) Bhanita Sharma et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Sex differences in Alzheimer's disease and other dementias
- (2016) Carolyn M Mazure et al. LANCET NEUROLOGY
- Alzheimer Disease and Its Growing Epidemic
- (2016) Richard A. Hickman et al. NEUROLOGIC CLINICS
- A review of caffeine’s effects on cognitive, physical and occupational performance
- (2016) Tom M. McLellan et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Intracerebroventricular Streptozotocin as a Model of Alzheimer’s Disease: Neurochemical and Behavioral Characterization in Mice
- (2016) Katherine Garcia Ravelli et al. NEUROTOXICITY RESEARCH
- Habitual coffee consumption and risk of cognitive decline/dementia: A systematic review and meta-analysis of prospective cohort studies
- (2016) Qing-Ping Liu et al. NUTRITION
- Coffee induces vascular endothelial growth factor (VEGF) expression in human neuroblastama SH-SY5Y cells
- (2016) Shota Kakio et al. NUTRITIONAL NEUROSCIENCE
- Meta-Analysis of the Association between Tea Intake and the Risk of Cognitive Disorders
- (2016) Qing-Ping Ma et al. PLoS One
- Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase
- (2016) Linfeng Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Early synaptic deficits in the APP/PS1 mouse model of Alzheimer’s disease involve neuronal adenosine A2A receptors
- (2016) Silvia Viana da Silva et al. Nature Communications
- Caffeine-Induced Suppression of GABAergic Inhibition and Calcium-Independent Metaplasticity
- (2016) Masako Isokawa NEURAL PLASTICITY
- 2015 Alzheimer's disease facts and figures
- (2015) Alzheimers & Dementia
- Early detection of cognitive deficits in the 3xTg-AD mouse model of Alzheimer's disease
- (2015) Kurt R. Stover et al. BEHAVIOURAL BRAIN RESEARCH
- Adenosine A2Areceptors are necessary and sufficient to trigger memory impairment in adult mice
- (2015) N Pagnussat et al. BRITISH JOURNAL OF PHARMACOLOGY
- Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?
- (2015) Simone Cappelletti et al. Current Neuropharmacology
- Rodent models for Alzheimer’s disease drug discovery
- (2015) Daniela Puzzo et al. Expert Opinion on Drug Discovery
- Rodent models of neuroinflammation for Alzheimer’s disease
- (2015) Amir Nazem et al. Journal of Neuroinflammation
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Caffeine prevents d-galactose-induced cognitive deficits, oxidative stress, neuroinflammation and neurodegeneration in the adult rat brain
- (2015) Faheem Ullah et al. NEUROCHEMISTRY INTERNATIONAL
- Caffeine Intake from Coffee or Tea and Cognitive Disorders: A Meta-Analysis of Observational Studies
- (2015) Young-Seok Kim et al. NEUROEPIDEMIOLOGY
- Caffeine Suppresses GABA Receptor-Mediated Current in Rat Primary Sensory Neurons via Inhibition of Intracellular Phosphodiesterase
- (2015) J. Y. Yang et al. NEUROPHYSIOLOGY
- Ferulic Acid: A Hope for Alzheimer’s Disease Therapy from Plants
- (2015) Antonella Sgarbossa et al. Nutrients
- Amyloid accumulation is a late event in sporadic Alzheimer’s disease-like pathology in nontransgenic rats
- (2015) Natalia A. Stefanova et al. Oncotarget
- From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?
- (2014) Vanessa Flaten et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Senescence-accelerated OXYS rats: A model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease
- (2014) Natalia Stefanova et al. CELL CYCLE
- Dual blockade of the A1 and A2A adenosine receptor prevents amyloid beta toxicity in neuroblastoma cells exposed to aluminum chloride
- (2014) Salvatore Giunta et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: A systematic review
- (2014) Francesco Panza et al. Journal of Nutrition Health & Aging
- Amyloid-Beta: A Crucial Factor in Alzheimer's Disease
- (2014) Saeed Sadigh-Eteghad et al. MEDICAL PRINCIPLES AND PRACTICE
- A2A adenosine receptor deletion is protective in a mouse model of Tauopathy
- (2014) C Laurent et al. MOLECULAR PSYCHIATRY
- Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology
- (2014) Cyril Laurent et al. NEUROBIOLOGY OF AGING
- Animal models of Alzheimer disease: historical pitfalls and a path forward
- (2014) Sarah E. Cavanaugh ALTEX-Alternatives to Animal Experimentation
- Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells
- (2014) Shu-Feng Zhou et al. Drug Design Development and Therapy
- A Transgenic Alzheimer Rat with Plaques, Tau Pathology, Behavioral Impairment, Oligomeric A , and Frank Neuronal Loss
- (2013) R. M. Cohen et al. JOURNAL OF NEUROSCIENCE
- Chronic caffeine treatment reverses memory impairment and the expression of brain BNDF and TrkB in the PS1/APP double transgenic mouse model of Alzheimer’s disease
- (2013) KUN HAN et al. Molecular Medicine Reports
- Modeling Alzheimer’s disease in transgenic rats
- (2013) Sonia Do Carmo et al. Molecular Neurodegeneration
- Association between caffeine intake and age at onset in Huntington's disease
- (2013) Clémence Simonin et al. NEUROBIOLOGY OF DISEASE
- Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine - searching for the connections
- (2012) Wojciech Danysz et al. BRITISH JOURNAL OF PHARMACOLOGY
- Crude caffeine reduces memory impairment and amyloid β1–42 levels in an Alzheimer’s mouse model
- (2012) Yi-Fang Chu et al. FOOD CHEMISTRY
- What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research
- (2012) Melita Salkovic-Petrisic et al. JOURNAL OF NEURAL TRANSMISSION
- Comparative Study on the Inhibitory Effect of Caffeic and Chlorogenic Acids on Key Enzymes Linked to Alzheimer’s Disease and Some Pro-oxidant Induced Oxidative Stress in Rats’ Brain-In Vitro
- (2012) Ganiyu Oboh et al. NEUROCHEMICAL RESEARCH
- Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells
- (2012) Natasa Dragicevic et al. NEUROPHARMACOLOGY
- Behavioral and Psychological Symptoms of Dementia
- (2012) J. Cerejeira et al. Frontiers in Neurology
- Protective Effect of Chlorogenic Acid against Aβ-Induced Neurotoxicity
- (2011) Chan-Woo Lee et al. Biomolecules & Therapeutics
- Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice
- (2011) Ross Zeitlin et al. BRAIN RESEARCH
- Animal models in the drug discovery pipeline for Alzheimer's disease
- (2011) Debby Van Dam et al. BRITISH JOURNAL OF PHARMACOLOGY
- In vitro modelling of Alzheimer's disease: Degeneration and cell death induced by viral delivery of amyloid and tau
- (2011) Sandra Stoppelkamp et al. EXPERIMENTAL NEUROLOGY
- Bioactivities of crude caffeine: Antioxidant activity, cyclooxygenase-2 inhibition, and enhanced glucose uptake
- (2011) Yi-Fang Chu et al. FOOD CHEMISTRY
- Epidemiology of Alzheimer disease
- (2011) Christiane Reitz et al. Nature Reviews Neurology
- Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice
- (2010) Paulo Henrique Botton et al. BEHAVIOURAL BRAIN RESEARCH
- Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice
- (2010) Seung-Hwan Kwon et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet
- (2010) Jaya R.P. Prasanthi et al. FREE RADICAL BIOLOGY AND MEDICINE
- Genetic Mechanisms of Coffee Extract Protection in a Caenorhabditis elegans Model of -Amyloid Peptide Toxicity
- (2010) V. Dostal et al. GENETICS
- NMDA-Mediated Ca2+ Influx Drives Aberrant Ryanodine Receptor Activation in Dendrites of Young Alzheimer's Disease Mice
- (2010) I. Goussakov et al. JOURNAL OF NEUROSCIENCE
- The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies
- (2010) Inge Klinkenberg et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Caffeine attenuates lipopolysaccharide-induced neuroinflammation
- (2010) Holly M. Brothers et al. NEUROSCIENCE LETTERS
- Neuroprotective Effects of (−)-Epigallocatechin-3-gallate on Aging Mice Induced by D-Galactose
- (2009) Miao He et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- The Role of Adenosine in Alzheimers Disease
- (2009) Anisur Rahman Current Neuropharmacology
- Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin-induced diabetic rats
- (2009) João M. N. Duarte et al. JOURNAL OF NEUROCHEMISTRY
- Adenosine A2A Receptor Blockade Prevents Synaptotoxicity and Memory Dysfunction Caused by -Amyloid Peptides via p38 Mitogen-Activated Protein Kinase Pathway
- (2009) P. M. Canas et al. JOURNAL OF NEUROSCIENCE
- Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease
- (2008) Xuesong Chen et al. Journal of Neuroinflammation
- Adenosine A2A receptor blockade prevents memory dysfunction caused by β-amyloid peptides but not by scopolamine or MK-801
- (2007) Geanne M.A. Cunha et al. EXPERIMENTAL NEUROLOGY
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
- Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
- (2007) Reinaldo Naoto Takahashi Frontiers in Bioscience-Landmark
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started